Evaluation of the efficacy of do-it-yourself versus commercialized automated insulin delivery systems
The IRCM clinic is searching for participants to participate in a research study that aims to compare commercially available automated insulin delivery (AID) systems and do-it-yourself (developed by patients) AID systems in terms of glucose control, safety and quality of life in real-life conditions in adults living with type 1 diabetes.
Participants have the possibility to gain knowledge that will enable them to better their current treatment.
This study involves 5 visits that can be undertaken over approximately 12 weeks:
- A first visit to determine your eligibility to participate in the study will take place either at the research center or by telephone/video conference. The duration of this visit is approximately 1.5 hours.
- If your first visit is at the IRCM, you will do visit 2 right after visit 1. If your first visit is online, you will be asked to schedule a date and time for visit 2 so that the study material can be sent to you. The duration of visit 2 is approximately 60 minutes.
- Three telephone visits to collect information on glucose control, safety, quality of life and insulin delivery. The duration of visit 3, 4 and 5 are approximately 40, 30 and 30 minutes, respectively.
- Living with type 1 diabetes for more than one year
- Be 18 years old and over
- Using an automated insulin delivery (AID) system for more than 3 months
514 914 1585